Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia

NCT00003620 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

NIH

Sponsor class

Conditions

B-cell Chronic Lymphocytic Leukemia
Refractory Chronic Lymphocytic Leukemia
Stage I Chronic Lymphocytic Leukemia
Stage II Chronic Lymphocytic Leukemia
Stage III Chronic Lymphocytic Leukemia
Stage IV Chronic Lymphocytic Leukemia

Interventions

DRUG: alvocidib
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)